Iron overload in myelodysplastic syndromes: a Canadian consensus guideline

Leukemia Research
|April 15, 2008
PubMed

Insights

Canadian hematologists developed a clinical practice guideline for treating iron overload in myelodysplastic syndromes (MDS). The guideline addresses diagnosis, monitoring, management, and treatment rationale for patients with MDS.

Area of Science:

  • Hematology
  • Clinical Practice Guidelines
  • Transfusional Iron Overload

Background:

  • Myelodysplastic syndromes (MDS) can lead to transfusional iron overload.
  • Effective management of iron overload is crucial for MDS patients.
  • Existing guidelines may not fully address practical clinical questions.

Framework:

  • Evidence-based approach utilizing literature search and expert consensus.
  • Focus on practical clinical questions: why, whom, when, and how to treat.
  • Development by a panel of Canadian hematologists with diverse practice experience.

Implementation:

  • Guideline development initiated in December 2005.
  • Involved 11 hematologists from major and rural Canadian centers.
  • Based on extensive literature review and clinical experience.

Implications:

  • Aims to standardize and improve the care of MDS patients with iron overload.
  • Provides a framework for clinicians managing iron overload in MDS.
  • Contributes to evidence-based decision-making in hematology practice.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...